Five hospitals in England and Wales have switched to urine test, rather than invasive hospital procedure ...
Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and precision medicine, today announced that the National Comprehensive Cancer Network® (NCCN®) has updated its Clinical Practice ...
Circulating tumor DNA, or ctDNA, can predict metastatic risk in patients who receive bladder-sparing treatment for muscle-invasive bladder cancer, but it is not a good predictor of local recurrence ...
Patients with muscle-invasive bladder cancer who test positive for circulating tumor (ct)DNA after surgery to remove the cancer benefit from immunotherapy with atezolizumab compared to placebo whereas ...
15don MSN
39% of women with bladder cancer were first told they had a UTI – these are the 9 symptoms to know
A consultant urologist explains why bladder cancer is often mistaken for a urinary tract infection in women – and the warning signs that should never be ignored ...
Fox Chase Cancer Center researchers reported positive results from the trial, known as RETAIN-2, demonstrating that a response-adapted bladder-preservation approach involving neoadjuvant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results